Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / news releases / COLL - Collegium Pharmaceutical: Low Multiples Justified Growth To Come At A Cost

COLL - Collegium Pharmaceutical: Low Multiples Justified Growth To Come At A Cost

Collegium Pharmaceutical Inc.

Summary

  • Collegium Pharmaceutical has caught a strong bid since bouncing off 52-week lows last October.
  • A number of catalysts have driven the stock up the page and shares now trade at multi-year highs.
  • The company projects strong growth prospects in FY23.
  • Delving deeper into the numbers, this growth looks like it will come at a cost to equity holders, justifying its low multiples.
  • Net-net, we rate COLL a hold.

For further details see:

Collegium Pharmaceutical: Low Multiples Justified, Growth To Come At A Cost
Stock Information
Company Name: Collegium Pharmaceutical Inc.
Stock Symbol: COLL
Market: NASDAQ
Website: collegiumpharma.com
Menu
COLL COLL Quote COLL Short COLL News COLL Articles COLL Message Board
Get COLL Alerts

News, Short Squeeze, Breakout and More Instantly...